On the 20th March 2012, Dr Mahbubur Rahman, Deputy Director, Analytical Process & Technology, Sanofi Pasteur, United States will be speaking on the above topic at the Biologic Manufacturing World Asia 2012, part of a series of conferences in the 5th Annual BioPharma Asia Convention 2012, held on 19-22 March at Marina Bay Sands, Singapore.
Dr Rahman is a process analytical expert with 19 years of leadership experiences in research, development, manufacturing, quality control of vaccines and biologics. His experiences include management of analytical process development laboratory operations, method development, qualification, and validation, GMP compliance, biologic product development and characterization; bioprocess QbD, scale-up operation, validation, and technology transfer. Dr Rahman?s specialties include physicochemical characterization of complex glycoprotein, monoclonal antibodies (MAbs), therapeutic protein, and glycoconjugate, analytical assay design, development, qualification, validation, and transfer, analytical control strategy, biological product development characterization, biologics process QbD, development, scale-up operation, and validation, cGMP, ICH, FDA, and EMEA guidelines, regulatory compliance, and quality management. To date he has presented more than 50 scientific presentations in national and international conferences. He is also the author/co-author of 30+ scientific papers published in internationally reported journals with peer review.
Dr Rahman will be addressing the following topics:
1. Understanding challenges in early bioprocess product analytical method development
2. Assessing innovative technologies to overcome analytical challenges
3. Implementing Process Analytical Technology (PAT) to control product critical quality attributes